Mirae Asset Global Investments Co. Ltd. Trims Stock Position in Xylem Inc. (NYSE:XYL)

Mirae Asset Global Investments Co. Ltd. lessened its position in shares of Xylem Inc. (NYSE:XYL) by 32.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 70,923 shares of the industrial products company’s stock after selling 34,434 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Xylem were worth $8,111,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Bruce G. Allen Investments LLC purchased a new stake in shares of Xylem during the 4th quarter valued at approximately $27,000. Coppell Advisory Solutions LLC acquired a new stake in Xylem in the 2nd quarter valued at approximately $45,000. KB Financial Partners LLC acquired a new stake in Xylem in the 1st quarter valued at approximately $42,000. ST Germain D J Co. Inc. acquired a new stake in Xylem in the 2nd quarter valued at approximately $46,000. Finally, NBC Securities Inc. acquired a new stake in Xylem in the 3rd quarter valued at approximately $38,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Stock Performance

Shares of XYL stock opened at $128.11 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.30 and a debt-to-equity ratio of 0.22. The firm has a fifty day moving average price of $126.36 and a 200 day moving average price of $111.24. The company has a market cap of $31.05 billion, a P/E ratio of 47.10, a PEG ratio of 2.55 and a beta of 1.10. Xylem Inc. has a 12 month low of $87.59 and a 12 month high of $130.86.

Xylem (NYSE:XYL) last issued its earnings results on Tuesday, February 6th. The industrial products company reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.03. The firm had revenue of $2.12 billion during the quarter, compared to the consensus estimate of $2.05 billion. Xylem had a net margin of 8.27% and a return on equity of 9.65%. The company’s revenue was up 40.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.92 earnings per share. Sell-side analysts predict that Xylem Inc. will post 4.13 earnings per share for the current fiscal year.

Xylem Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 20th. Investors of record on Wednesday, February 21st were given a $0.36 dividend. The ex-dividend date of this dividend was Tuesday, February 20th. This is a boost from Xylem’s previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a yield of 1.12%. Xylem’s payout ratio is 52.94%.

Insider Activity at Xylem

In related news, SVP Franz Cerwinka sold 2,408 shares of the business’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the sale, the senior vice president now directly owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the transaction, the senior vice president now directly owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the transaction, the chief accounting officer now directly owns 2,935 shares of the company’s stock, valued at $360,682.15. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several analysts recently weighed in on XYL shares. BNP Paribas started coverage on shares of Xylem in a report on Tuesday, March 12th. They issued an “outperform” rating and a $150.00 target price for the company. Robert W. Baird lifted their target price on shares of Xylem from $141.00 to $148.00 and gave the company an “outperform” rating in a report on Thursday, March 21st. Citigroup boosted their price target on shares of Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a research note on Monday, April 8th. Raymond James upgraded shares of Xylem from an “underperform” rating to a “market perform” rating in a research note on Thursday, January 4th. Finally, Stifel Nicolaus boosted their price target on shares of Xylem from $136.00 to $150.00 and gave the stock a “buy” rating in a research note on Wednesday, February 7th. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $135.44.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.